Application
Fig5: Flow cytometric analysis of HepG2 cells with Alpha-1 Acid Glycoprotein antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Application
Fig5: Flow cytometric analysis of HepG2 cells with Alpha-1 Acid Glycoprotein antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Application
Fig5: Flow cytometric analysis of HepG2 cells with Alpha-1 Acid Glycoprotein antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Application
Fig5: Flow cytometric analysis of HepG2 cells with Alpha-1 Acid Glycoprotein antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Application
Fig5: Flow cytometric analysis of HepG2 cells with Alpha-1 Acid Glycoprotein antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.